PyInvesting

Market research

1J5.SG HYPHENS PHARMA INTL LIMITED

Current ticker: 1J5.SG

SG SGD Healthcare

Latest close

0.345 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
108M
P/E ratio
11.67
Analyst target
0.46
Dividend yield
4.2%
Beta
0.23

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Hyphens Pharma International Limited is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.

From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.

Hyphens Pharma International Limited's total revenue sank by 6.5% to $31M since the same quarter in the previous year.

Its net income has dropped by 37.8% to $1M since the same quarter in the previous year.

Finally, its free cash flow fell by 20.0% to $2M since the same quarter in the previous year.

Based on the above factors, Hyphens Pharma International Limited gets an overall score of 1/5.